Published in Mol Ther on August 01, 2001
Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing. J Clin Invest (2003) 1.14
5' exon replacement and repair by spliceosome-mediated RNA trans-splicing. RNA (2003) 1.13
Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies. Proc Natl Acad Sci U S A (2005) 1.10
Exon exchange approach to repair Duchenne dystrophin transcripts. PLoS One (2010) 1.02
A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Res (2011) 0.95
Using 5'-PTMs to repair mutant beta-globin transcripts. RNA (2007) 0.94
Cis-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing. Mol Ther (2014) 0.92
Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders. Mol Ther Nucleic Acids (2014) 0.89
Lessons from non-canonical splicing. Nat Rev Genet (2016) 0.88
Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing. Proc Natl Acad Sci U S A (2004) 0.87
Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa. Mol Ther (2015) 0.85
Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo. Mol Ther (2008) 0.83
Replacement of huntingtin exon 1 by trans-splicing. Cell Mol Life Sci (2012) 0.80
Functional repair of p53 mutation in colorectal cancer cells using trans-splicing. Oncotarget (2015) 0.80
Gene repair by means of trans-splicing: a delicate balancing act between efficiency and specificity? Mol Ther (2001) 0.78
Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model. PLoS Genet (2015) 0.77
mRNA trans-splicing in gene therapy for genetic diseases. Wiley Interdiscip Rev RNA (2016) 0.77
Proximity-dependent and proximity-independent trans-splicing in mammalian cells. RNA (2008) 0.76
Targeting Splicing in the Treatment of Human Disease. Genes (Basel) (2017) 0.75
Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells. Mol Ther Nucleic Acids (2017) 0.75
In vitro transcription of adenovirus. J Virol (1981) 7.06
Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors. Nature (1994) 6.97
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
Messenger RNA for the Ad2 DNA binding protein: DNA sequences encoding the first leader and heterogenity at the mRNA 5' end. Cell (1979) 5.28
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol (1981) 5.01
Polypyrimidine tract binding protein antagonizes exon definition. Mol Cell Biol (2001) 4.10
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J (1987) 3.77
Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery (1983) 3.65
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol (1989) 3.55
Characterization of cDNAs encoding the polypyrimidine tract-binding protein. Genes Dev (1991) 3.55
Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus. Proc Natl Acad Sci U S A (1990) 2.92
Epidemiology of trauma deaths. Am J Surg (1980) 2.58
Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol (1994) 2.49
Transient replication of human papillomavirus DNAs. J Virol (1992) 2.43
Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA (1997) 2.43
Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat Biotechnol (1999) 2.32
Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol Cell Biol (1998) 2.23
An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol Cell Biol (2000) 2.08
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07
A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J Biol Chem (1993) 2.02
SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome. RNA (1995) 2.02
Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene (2001) 2.02
A comparison of the association of helicopter and ground ambulance transport with the outcome of injury in trauma patients transported from the scene. J Trauma (1997) 1.97
Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest (1979) 1.94
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
The spliceosome assembly pathway in mammalian extracts. Mol Cell Biol (1992) 1.78
U1 snRNP-ASF/SF2 interaction and 5' splice site recognition: characterization of required elements. Nucleic Acids Res (1995) 1.77
Exon circularization in mammalian nuclear extracts. RNA (1996) 1.76
The genetics of bovine papillomavirus type 1. Annu Rev Genet (1988) 1.75
Acute appendicitis following blunt abdominal trauma. Incidence or coincidence? Ann Surg (1991) 1.72
An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J Virol (1991) 1.68
The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol (2001) 1.64
An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol Cell Biol (1998) 1.64
RNA binding by Sxl proteins in vitro and in vivo. Mol Cell Biol (1994) 1.63
Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene (1997) 1.63
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Predicting fatal sepsis in burn patients. J Trauma (1979) 1.54
Biogenesis, structures, and sites of encoding of the 5' termini of adenovirus-2 mRNAs. Cold Spring Harb Symp Quant Biol (1980) 1.52
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology (2004) 1.49
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro. Thromb Res (2006) 1.47
The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock (1996) 1.46
Evaluation of an instrumented walkway for measurement of the kinematic parameters of gait. Gait Posture (2000) 1.40
Epidemiology of trauma: the civilian perspective. Ann Emerg Med (1986) 1.39
Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J Virol (1996) 1.39
Murine polypyrimidine tract binding protein. Purification, cloning, and mapping of the RNA binding domain. J Biol Chem (1991) 1.37
A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc Natl Acad Sci U S A (1998) 1.37
Cardiac contusion. The effect on operative management of the patient with trauma injuries. Arch Surg (1989) 1.37
Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II. Proc Natl Acad Sci U S A (2000) 1.36
CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol Cell Biol (1997) 1.36
Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg (1986) 1.34
Coupled in vitro synthesis and splicing of RNA polymerase II transcripts. RNA (2000) 1.29
The role of emergency room thoracotomy in trauma. J Trauma (1980) 1.27
Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5'-noncoding region. J Med Virol (1995) 1.22
Cystoid macular edema in pseudophakia. Surv Ophthalmol (1984) 1.21
Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol (1993) 1.21
Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Neurology (1997) 1.20
Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-beta 1. Mol Endocrinol (1987) 1.19
Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J Virol (1995) 1.16
Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma (1987) 1.12
Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis (2005) 1.11
Use of image analysis to quantitate changes in form of mitochondrial DNA after x-irradiation. Appl Theor Electrophor (1989) 1.10
Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther (2000) 1.10
Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma (1994) 1.09
Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers. J Virol (1997) 1.09
Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci U S A (1994) 1.08
A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding. J Biol Chem (1998) 1.08
Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo. J Virol (2000) 1.08
Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner. Mol Cell Biol (1999) 1.08
Unusual structure of the human immunodeficiency virus type 1 trans-activation response element. J Virol (1992) 1.07
Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis: discussion. J Thromb Haemost (2015) 1.06
Regulation of DNA replication in S phase nuclei by ATP and ADP pools. Proc Natl Acad Sci U S A (1979) 1.06
Nonoperative management of adult blunt splenic trauma. Criteria for successful outcome. Ann Surg (1989) 1.04
An analysis of the association of trauma centers with per capita hospitalizations and death rates from injury. Ann Surg (1993) 1.04
Accuracy of administrative data in trauma. Surgery (1999) 1.04
Poly(A) sites of adenovirus serotype 2 transcription units. J Mol Biol (1982) 1.04
An ATP-independent U2 small nuclear ribonucleoprotein particle/precursor mRNA complex requires both splice sites and the polypyrimidine tract. Proc Natl Acad Sci U S A (1992) 1.03
Mitochondrial DNA sequence analysis of human skeletal remains: identification of remains from the Vietnam War. J Forensic Sci (1993) 1.02
Intraocular lenses: complications and visual results. Trans Am Ophthalmol Soc (1983) 0.98
Identity of mononuclear cells which compromise the resistance of trauma patients. J Surg Res (1979) 0.98
Comparison of the ability of adult and pediatric trauma scores to predict pediatric outcome following major trauma. J Trauma (1991) 0.98
Structural features of an RNA containing the CUGGGA loop of the human immunodeficiency virus type 1 trans-activation response element. Biochemistry (1993) 0.98
A statewide, population-based time-series analysis of the increasing frequency of nonoperative management of abdominal solid organ injury. Ann Surg (1995) 0.96
Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia. J Thromb Haemost (2008) 0.96
Antithrombotic therapy in children. Curr Opin Pediatr (1999) 0.96
Management outcomes in splenic injury: a statewide trauma center review. Ann Surg (1997) 0.96
Promoters of bovine papillomavirus type 1: in vitro activity and utilization. J Virol (1988) 0.95
The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region. Mol Cell Biol (1995) 0.95
Effect of human gamma interferon on yellow fever virus infection. Am J Trop Med Hyg (1988) 0.95
Vascular injuries in a rural state: a review of 978 patients from a state trauma registry. J Trauma (1992) 0.95
A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription. Nucleic Acids Res (1996) 0.95
A novel isoform ratio switch of the polypyrimidine tract binding protein. Electrophoresis (1999) 0.95
15's: they fit in everywhere--especially the school bag: a survey of purchases of packets of 15 cigarettes by 14 and 15 year olds in South Australia. Community Health Stud (1987) 0.94
On the analysis of circular dichroic spectra of proteins. Biochemistry (1976) 0.94
Pancreatic injuries resulting from penetrating trauma: a multi-institution review. Am Surg (1998) 0.93
Functional conservation of the human homolog of the yeast pre-mRNA splicing factor Prp17p. J Biol Chem (1998) 0.93